Akero Therapeutics Inc (AKRO) Insider Trading
- $44,791,272.50
- $136,554,807.78
- Nov. 1, 2024
- Andrew Cheng
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 3, 2021 | CEO | 17,500 | $20.83 | Sell | $364,525.00 | |
| Aug. 2, 2021 | CFO | 4,441 | $22.03 | Sell | $97,835.23 | |
| July 15, 2021 | Insider | 10,000 | $20.90 | Sell | $209,000.00 | |
| July 6, 2021 | CFO | 6,500 | $24.52 | Sell | $159,380.00 | |
| July 2, 2021 | CEO | 17,500 | $24.78 | Sell | $433,650.00 | |
| June 1, 2021 | Director | 17,489 | $26.28 | Sell | $459,610.92 | |
| April 1, 2021 | COO | 3,055 | $28.75 | Sell | $87,831.25 | |
| April 1, 2021 | CFO | 50,000 | $28.64 | Sell | $1,432,000.00 | |
| March 1, 2021 | COO | 3,055 | $30.48 | Sell | $93,116.40 | |
| Feb. 1, 2021 | COO | 3,055 | $29.24 | Sell | $89,328.20 | |
| Jan. 8, 2021 | COO | 10,000 | $28.12 | Sell | $281,200.00 | |
| Jan. 4, 2021 | COO | 3,060 | $25.29 | Sell | $77,387.40 | |
| Oct. 9, 2020 | Director | 13,000 | $28.93 | Sell | $376,090.00 | |
| July 10, 2020 | Major Shareholder | 415,000 | $36.00 | Buy | $14,940,000.00 | |
| July 6, 2020 | Major Shareholder | 4,603 | $33.83 | Sell | $155,719.49 | |
| July 1, 2020 | Major Shareholder | 108,064 | $34.45 | Sell | $3,722,804.80 | |
| June 24, 2019 | Major Shareholder | 250,000 | $16.00 | Buy | $4,000,000.00 | |
| June 24, 2019 | Director | 900,000 | $16.00 | Buy | $14,400,000.00 | |
| June 21, 2019 | Director | 67,829 | $2.50 | Buy | $169,572.50 |
Insiders are both buying and selling Akero Therapeutics Inc stock.
The insider traders at Akero Therapeutics Inc are: Andrew Cheng, Jonathan Young, Catriona Yale, William Richard White, Timothy Rolph, G. Walmsley Graham, Seth Loring Harrison, Global Strategic Fund I Venbio, Kevin Bitterman, Patrick Lamy, Skorpios Trust, Aaron Royston, Tomas J. Heyman, and Apple Tree Partners Iv, L.P.
The most active insider trader at Akero Therapeutics Inc is Andrew Cheng with 27 trades.
Skorpios Trust has sold the most Akero Therapeutics Inc stock with a total value of $142,332,000.00.
Apple Tree Partners Iv, L.P. has bought the most Akero Therapeutics Inc stock with a total value of $29,880,000.00.
The most recent insider trade for Akero Therapeutics Inc was on Nov. 1, 2024.
The single biggest insider buy for Akero Therapeutics Inc was from Apple Tree Partners Iv, L.P. with a total value of $14,940,000.00 on July 10, 2020.
The single biggest insider sell for Akero Therapeutics Inc was from Skorpios Trust with a total value of $71,166,000.00 on Dec. 1, 2022.